![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, August 08, 2017 12:44:31 PM
You don't want to short something you can't cover, but stocks fail in the OTC all the time. DRYS has been a great example of that historically. R/S then short into the ground like clockwork.
On the other side, what I'm seeing on USRM chart is a near term historic low in price. You'll see about 6 months ago that they were trading at next to nothing, but as of the last 3 months have added and are holding value. The pop to .17 was clearly artificial, but they'd REALLY have to throw the game to go much lower than this with the current interest in stem cell tech. That said, the company still needs to provide investors with knowledge that USRM is doing well on the business side and making money. Severe losses would be unacceptable, and it appears that focusing profit was their big goal in dropping RMAT pursuit for the time being.
They need to innovate, advance AND profit. No point in being cutting edge if you can't make a buck.
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM
PickleJar Unveils Latest Venue Managed Services Innovations in Upcoming Webinar • PKLE • Aug 23, 2024 1:11 PM
Element79 Gold Corp Provides Update on Nevada Portfolio • ELMGF • Aug 23, 2024 8:00 AM